Register entry
ASCENDIS PHARMA BONE DISEASES AS
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 27
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
27| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8906847 | YORVIPATHpalopegteriparatide | substance, product | Apr 2031 |
| 11590207 | YORVIPATHpalopegteriparatide | use | Sept 2037 |
| 11759504 | YORVIPATHpalopegteriparatide | product | Sept 2037 |
| 11857603 | YORVIPATHpalopegteriparatide | use | Sept 2037 |
| 11890326 | YORVIPATHpalopegteriparatide | substance, product | Sept 2037 |
| 11918628 | YORVIPATHpalopegteriparatide | substance, product | Sept 2037 |
| 12295989 | YORVIPATHpalopegteriparatide | use | Sept 2037 |
| 12453778 | YORVIPATHpalopegteriparatide | use | Sept 2037 |
| 12403182 | YORVIPATHpalopegteriparatide | product | Nov 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| YORVIPATHPALOPEGTERIPARATIDE | ODE-492 Orphan drug | Aug 2031 |
Enquiry
Common questions
- Is ASCENDIS PHARMA BONE DISEASES AS FDA approved?
- ASCENDIS PHARMA BONE DISEASES AS holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.